New HPO release for June 2019


Dear HPO community,

the HPO consortium is announcing the June 2019 release of HPO and its associated resources.

Since the last release we have added 62 new OMIM entries and provide annotation updates for > 700 OMIM entries with a total of > 2000 new HPO-disease associations. Especially, there are new inheritance annotations to improve inheritance-mode-aware algorithms operating on HPO data.

We have added 2 new terms for LOINC annotations, as well as new synonyms to Triggered by (HP_0025204), Aggravated by (HP_0025285) terms, and Ameliorated by (HP_0025254). We added logical definitions to HP_0410282 'Abnormal circulating amylase level' and children terms. 'Abnormal hepatic iron concentration' was moved to be a child of 'Abnormal tissue metabolite concentration'. Further work has been done to enable the DOSDP/ODK pipeline that was started with the last release of HPO. Finally, we have fixed a lot of typos in text definitions and term labels.

As a side note: we have just made our 5000th commit to the HPO repository since our move to GitHub (see

We hope the above described changes are useful to our users. Should you need any further information, please do not hesitate to contact us or file an issue on our tracker at

the HPO Team

Prof. Dr. Sebastian Köhler
Berlin Institute of Health | Charité | Einstein Center Digital Future | | |

Diese Nachricht (inklusive aller Anhänge) ist vertraulich. Sie darf ausschließlich durch den vorgesehenen Empfänger und Adressaten gelesen, kopiert oder genutzt werden. Sollten Sie diese Nachricht versehentlich erhalten haben, bitten wir, den Absender (durch Antwort-E-Mail) hiervon unverzüglich zu informieren und die Nachricht zu löschen. Jede unerlaubte Nutzung oder Weitergabe des Inhalts dieser Nachricht, sei es vollständig oder teilweise, ist unzulässig. Bitte beachten Sie, dass E-Mail-Nachrichten an den Absender nicht für fristgebundene Mitteilungen geeignet sind. Fristgebundene Mitteilungen sind daher ausschließlich per Post oder per Telefax zu übersenden. Wir haben diese E-Mail beim Ausgang einer Virenkontrolle unterzogen, raten aber wegen der Gefahr einer Kontamination auf den Übertragungswegen zu einer Vireneingangskontrolle. Eine Haftung für Virenfreiheit schließen wir aus.

This message (including any attachments) is confidential and may be privileged. It may be read, copied and used only by the intended recipient. If you have received it in error please contact the sender (by return e-mail) immediately and delete this message. Any unauthorised use or dissemination of this message in whole or in part is strictly prohibited. Please note that, for organisational reasons, the personal e-mail address of the sender is not available for matters subject to a deadline. Therefore, please send matters subject to deadline exclusively by mail or by fax. This e-mail was checked for virus contamination before being sent. Nevertheless it is advisable to check for any contamination occuring during transmission. We cannot accept any liability for virus contamination.